# GLP-1s and Cancer Part 3 - The Guardian Article

Page: https://stenobird.com/podcast/weight-and-healthcare-6448206/glp-1s-and-cancer-part-3-the-guardian-article
Text version: https://stenobird.com/podcast/weight-and-healthcare-6448206/glp-1s-and-cancer-part-3-the-guardian-article.md
Podcast: [Weight and Healthcare](https://stenobird.com/podcast/weight-and-healthcare-6448206)
Published: 2026-06-20T17:00:00+00:00
Episode link: https://weightandhealthcare.substack.com/p/glp-1s-and-cancer-part-3-the-guardian
Audio file: https://api.substack.com/feed/podcast/202253940/ef6c18e5e6c02c00cdb9fcaf83980fb1.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/weight-and-healthcare-6448206/episodes/glp-1s-and-cancer-part-3-the-guardian-article
Duration seconds: 532

## Resource

In part 1 we discussed the basics around the current studies considering possible impacts of GLP-1s on cancer (if you haven’t read part 1 yet you might want to as I will refer to the things discussed in that post.) In part 2 we looked at a study that explored correlation between GLP-1 use and cis women with breast cancer. Today we’re going to look at a Guardian Article that many of you asked me to discuss. Get full access to Weight and Healthcare at weightandhealthcare.substack.com/subscribe

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/weight-and-healthcare-6448206/episodes/glp-1s-and-cancer-part-3-the-guardian-article/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/weight-and-healthcare-6448206/glp-1s-and-cancer-part-3-the-guardian-article.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.